Abstract Background High-risk HPV DNA testing has been proposed as a primary tool for cervical cancer screening (HPV-CCS) as an alternative to the Papanicolaou cytology- method. This study describes factors associated with women’s intentions to attend cervical cancer screening if high-risk HPV DNA testing (HPV-CCS) was implemented as a primary screening tool, and if screening were conducted every 4 years starting after age 25. Methods This online survey was designed using the Theory of Planned Behaviour to assess factors that impact women’s intentions to attend HPV-CCS among women aged 25–69 upon exit of the HPV FOCAL trial. Univariate and regression analyses were performed to compare the demographic, sexual history, and smoking characteris...
BACKGROUND: Compared to the previous cytology-based program, the introduction of primary high-risk h...
HPV vaccination programs have adversely affected participation in future cervical cancer screening. ...
HPV vaccination programs have adversely affected participation in future cervical cancer screening. ...
Background High-risk HPV DNA testing has been proposed as a primary tool for cervic...
Background High-risk HPV DNA testing has been proposed as a primary tool for cervical cancer screeni...
Background High-risk HPV DNA testing has been proposed as a primary tool for cervical cancer screen...
We explored the potential impact of HPV testing on women’s intentions to be screened for cervical ca...
We explored the potential impact of HPV testing on women’s intentions to be screened for cervical ca...
We explored the potential impact of human papillomavirus (HPV) testing on women's intentions to be s...
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards imple...
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards imple...
Cervical cancer screening and prevention has been one of the great success stories in public health,...
Background Countries must decide whether or not to replace primary cytology-based screening with pri...
Background: Cervical screening programs target entire populations, although it is well established t...
Background: Cervical screening programs target entire populations, although it is well established t...
BACKGROUND: Compared to the previous cytology-based program, the introduction of primary high-risk h...
HPV vaccination programs have adversely affected participation in future cervical cancer screening. ...
HPV vaccination programs have adversely affected participation in future cervical cancer screening. ...
Background High-risk HPV DNA testing has been proposed as a primary tool for cervic...
Background High-risk HPV DNA testing has been proposed as a primary tool for cervical cancer screeni...
Background High-risk HPV DNA testing has been proposed as a primary tool for cervical cancer screen...
We explored the potential impact of HPV testing on women’s intentions to be screened for cervical ca...
We explored the potential impact of HPV testing on women’s intentions to be screened for cervical ca...
We explored the potential impact of human papillomavirus (HPV) testing on women's intentions to be s...
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards imple...
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards imple...
Cervical cancer screening and prevention has been one of the great success stories in public health,...
Background Countries must decide whether or not to replace primary cytology-based screening with pri...
Background: Cervical screening programs target entire populations, although it is well established t...
Background: Cervical screening programs target entire populations, although it is well established t...
BACKGROUND: Compared to the previous cytology-based program, the introduction of primary high-risk h...
HPV vaccination programs have adversely affected participation in future cervical cancer screening. ...
HPV vaccination programs have adversely affected participation in future cervical cancer screening. ...